Prophylactic Medium-Class Topical Steroids are Associated with a Lower Incidence of Capecitabine-Induced Hand-Foot Syndrome in Patients with Colorectal Cancer

Study limitation reported by the research below: “Topical steroid potency classification used is based on the Japanese Dermatological Association system; hydrocortisone butyrate 0.1% and clobetasone butyrate 0.05% correspond approximately to US class 5 (medium potency), but equivalence mapping across systems should be confirmed locally.”